Seattle

03/11/2017 Conference IBDH Seattle 2017

Biosimilar Talk – B. Feagan vs A. Afzali
Perioperative therapies Talk – F. Remzi vs S. Hanauer
De-escalation therapy – B. Abraham vs S. D. Lee
Nutrition based therapies – G. Wahbeh vs D. Suskind
Case Study – De-escalation


2017

March 11

8:00 am

Details

  • Start: March 11 2017, 8:00 am
  • End: March 11 2017, 3:30 pm
  • Cost: FREE
  • Credits: CME 6 Credits

Housing


  • Seattle Marriott Waterfront
  • 2100 Alaskan Way, Seattle, WA 98121 – (800) 228-9290
  • Mention IBD Horizon Educational Room Block group to receive preferential room rates (Deadline Feb-16)

Agenda


Topic
07:00 – Breakfast
08:00 – Start of meeting
08:15 – Biosimilar Talk – B. Feagan vs A. Afzali
09:35 – Perioperative therapies Talk – F. Remzi vs S. Hanauer
11:10 – Case Study – Biosimilars
12:00 – Lunch
12:40 – De-escalation therapy – B. Abraham vs S. D. Lee
01:45 – Nutrition based therapies – G. Wahbeh vs D. Suskind
02:45 – Case Study – De-escalation
03:30 – Adjourn

VENUE : BELL HARBOR CONFERENCE CENTER


Learning Objectives


After completion of this activity, participants will be able to:

  1. Understand the implications regarding cost and effectiveness of biosimlar medications in the treatment of IBD.
  2. Understand the effect of nutritional and dietary intervention in patients.
  3. Assess if patients who are currently on effective therapy the implications of discontinuation of or decrease in doses of either immune suppressive medication or biologic therapy.
  4. Assess the risks of ongoing medical therapy for IBD patients undergoing surgical intervention.

Video


Media

CONFERENCE

Speakers



Scott

Lee


Anita

Afzali


Bincy

Abraham


Stephen

B.Hanauer


Brian

Feagan


Feza

Remzi


Ghassan

Wahbeh


Target Audience


180

– Adult and pediatric gastroenterologists
– Advanced registered nurse practitioners
– Registered nurses providing care for IBD patients
– Physician assistants
– Pharmacists providing care for IBD patients.
IBD Focused

Statement of Need/Program Overview


Statement

The management of IBD is highly dynamic with extensive, cutting-edge information deriving from a wealth of ongoing scientific, clinical, and therapeutic research programs. The mission of IBD Horizons® is to provide healthcare providers the opportunity to enhance their clinical knowledge by providing the most up-to-date information regarding the management of IBD. Cutting edge topics delivered by respected educators/leaders in the IBD field, as well as opportunities for interaction between the presenters and participants have been designed into the educational program.

Credits


6 CME Credits

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and IBD Horizons. Global is accredited by the ACCME to provide continuing medical education for physicians.

* This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.

This educational activity for 6.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Global Education Group designates this continuing education activity for 6.0 contact hours (0.6 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-16-104-L01-P)

This is a knowledge based activity.